Skip to content

Tag: Parkinson s disease

Explore our medication guides and pharmacology articles within this category.

Understanding What istradefylline used for?

5 min read
Approved by the FDA in 2019, istradefylline (brand name Nourianz) is the first-in-class, non-dopaminergic medication used as an adjunctive treatment for adult patients with Parkinson's disease who experience 'off' episodes. It works alongside levodopa/carbidopa to manage the motor fluctuations associated with the disease.

What Medications Can Cause Compulsive Behavior? A Guide to Recognizing Risks

4 min read
According to the U.S. Food and Drug Administration (FDA), medications like the antipsychotic aripiprazole have been linked to rare but serious impulse-control problems, such as compulsive gambling and binge eating. It is crucial for patients and their caregivers to be aware of what medications can cause compulsive behavior, as these urges can have a significant impact on an individual's life if left unaddressed.

What is the main medication used to treat Parkinson's disease?

4 min read
Parkinson's disease, affecting millions globally, is primarily caused by a decline in dopamine-producing neurons in the brain. The most effective and main medication used to treat Parkinson's disease is levodopa, which helps to replace the missing dopamine and manage motor symptoms.

What is the best medication to help with tremors?

4 min read
Affecting approximately 10 million Americans, essential tremor is the most common movement disorder, but it is not the only cause of tremors. Finding the right treatment requires an accurate diagnosis, as the answer to 'What is the best medication to help with tremors?' depends heavily on the underlying condition.

Understanding if Amantadine Causes Shaking and Other Movement Issues

4 min read
While most commonly known for treating movement disorders, research and postmarketing experience have shown that amantadine can, in some cases, cause abnormal movements, including shaking or myoclonus. It is crucial for patients and healthcare providers to understand this paradoxical risk when considering therapy.

What is the classification of rotigotine?

4 min read
Rotigotine (brand name Neupro), a medication for Parkinson's disease and Restless Legs Syndrome, is classified as a non-ergoline dopamine agonist that utilizes a unique transdermal patch for continuous delivery. This provides a stable medication level, mimicking physiological dopamine stimulation and avoiding the peaks and troughs associated with oral administration.